U.S. drugmaker Pfizer Inc. has signed a deal with Germany’s BioNTech SE to codevelop a potential vaccine for the coronavirus using BioNTech’s mRNA-based drug development platform, the companies said on…

Read more »

The post Pfizer, BioNTech to Codevelop Potential Coronavirus Vaccine appeared first on Hamodia.

In related news:

  1. Government Official: Coronavirus Vaccine Trial Starts Monday
  2. British Drugmaker GSK to Collaborate With CEPI in Effort to Develop Coronavirus Vaccine
  3. U.S. Panel Recommends New Adult Vaccine Against Hepatitis B
  4. Swiss Agency Approves Trial for Ebola Vaccine
  5. Penn. Firm Launches Zika Vaccine Trial in Puerto Rico